Target intelligence / Profile preview

Pseudogene similar to ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (ENSG00000236960 (no widely used abbreviation))

Target
ENSG00000236960 (no widely used abbreviation)
Molecular classification
Other (pseudogene)
01

Overview

ENSG00000236960 represents a pseudogene similar to part of the ATP2A2 gene, which encodes the enzyme sarco(endo)plasmic reticulum calcium-ATPase 2 (SERCA2)[1][5]. ATP2A2 is an important calcium transporter in muscle and other cells[4][2], but this pseudogene does not code for a functional protein and is not considered a drug target or associated with specific biological pathways or drug interactions. Pseudogenes are typically non-functional DNA sequences derived from functional genes, often lacking necessary coding or regulatory elements. This entry should not be considered a valid therapeutic target, as it is a pseudogene and not a functional receptor, transporter, enzyme, or other protein target[5][1]. If you are seeking information about the functional target, refer instead to ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 (ATP2A2, also known as SERCA2)[4][2], which IS a well-characterized therapeutic target in certain contexts (e.g., cardiac disease, Darier disease). ENSG00000236960 refers to a pseudogene, not a druggable protein target, and does not have documented biological activity, disease association, or clinical relevance[5][1]. ENSG00000236960 is a pseudogene similar to part of ATP2A2 (SERCA2) and does not possess the features of a valid drug target.

Other names
ATP2A2 pseudogenePseudogene similar to ATPase, Ca++ transporting, cardiac muscle, slow twitch 2

Beyond the preview

Go deeper on Pseudogene similar to ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (ENSG00000236960 (no widely used abbreviation)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudogene similar to ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (ENSG00000236960 (no widely used abbreviation)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call